Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Join us and our co-hosts for this free virtual event on 28-29th April 2021 to hear the latest developments from international leaders in these fields


 

Cancer Research UK Oxford Centre, alongside Ludwig Cancer Research and the Oxford Centre for Early Cancer Detection, are co-hosting the Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics on 28 – 29 April 2021.

Registration is now open for an exciting programme of talks on the latest developments in cancer early detection and cancer epigenetics research.

Open to all – and suitable for scientists in basic, translational or clinical research – this free virtual event will bring together international leaders in these fields to discuss key advances and stimulate ideas.

Topics will include Early Detection TechnologiesRisk Stratification for Early Cancer DetectionChromatin and Cancerand Nucleic Acid Modifications and CancerSessions will run from approximately 15:00-19:00 (London)/10:00-14:00 (New York) each day.

Confirmed speakers include:

  • Naomi Allen (University of Oxford)
  • Eleanor Barnes (University of Oxford)
  • Stephen B. Baylin (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Shelley Berger (University of Pennsylvania)
  • Sangeeta Bhatia (Ludwig Cancer Research, Massachusetts Institute of Technology)
  • Chuan He (Ludwig Cancer Research, University of Chicago)
  • Nada Jabado (McGill University)
  • Cigall Kadoch (Ludwig Cancer Research, Dana Farber Cancer Institute)
  • Kenneth W. Kinzler (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Tony Kouzarides (University of Cambridge)
  • Nickolas Papadopoulos (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Gillian Reeves (University of Oxford)
  • Jens Rittscher (Ludwig Cancer Research, University of Oxford)
  • Yang Shi (Ludwig Cancer Research, University of Oxford)
  • Chunxiao Song (Ludwig Cancer Research, University of Oxford)

Please register for the event here.

Enquiries should be directed to conference@ludwig.ox.ac.uk

 

Similar Stories

Cancer at Oxford

Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series

Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer

The National Cancer Imaging Translational Accelerator (NCITA) in partnership with the ReIMAGINE Consortium have announced the release of a unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS)).

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Swietach Group scientists have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes